Ernst Schlögl
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Acute Myeloid Leukemia Research 4
- Chronic Myeloid Leukemia Treatments 4
- Genetics 6
- Chronic Lymphocytic Leukemia Research 3
- Myeloproliferative Neoplasms: Diagnosis and Treatment 3
- Co-authors
- Heinz Gisslinger (3 shared papers)E. Pittermann (2 shared papers)R. Heinz (3 shared papers)Robert Pytlík (1 shared paper)Michael Pfeilstöcker (2 shared papers)Guenther Gastl (1 shared paper)Michael Steurer (1 shared paper)Heinz Tüchler (2 shared papers)
In The Last Decade
Ernst Schlögl
14 papers receiving 285 citations
Peers
Comparison fields: 5 of 36
- Hematology 165
- Genetics 146
- Rheumatology 47
- Pathology and Forensic Medicine 40
- Molecular Biology 99
Countries citing papers authored by Ernst Schlögl
This map shows the geographic impact of Ernst Schlögl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ernst Schlögl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ernst Schlögl more than expected).
Fields of papers citing papers by Ernst Schlögl
This network shows the impact of papers produced by Ernst Schlögl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ernst Schlögl. The network helps show where Ernst Schlögl may publish in the future.
Co-authors
The 25 scholars most cited alongside Ernst Schlögl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 67 | |
| 2 | 2004 | 55 | |
| 3 | 2017 | 38 | |
| 4 | 1996 | 37 | |
| 5 | 2010 | 37 | |
| 6 | 1983 | 19 | |
| 7 | Karyotype and prognosis in non-Hodgkin lymphoma. | 1994 | 17 |
| 8 | 2003 | 6 | |
| 9 | 2013 | 4 | |
| 10 | 1995 | 4 | |
| 11 | Minor BCR (m-bcr) rearrangements may appear in major BCR (M-bcr)-positive CML cases. | 1992 | 4 |
| 12 | 2010 | 2 | |
| 13 | A european observational study of dasatinib in the management of imatinib-resistant and -intolerant patients with chronic myeloid leukemia: forte study (ca180-211) | 2010 | 1 |
| 14 | 1997 | 1 |
About Ernst Schlögl
Ernst Schlögl is a scholar working on Hematology, Genetics, Molecular Biology, Pathology and Forensic Medicine and Rheumatology, having authored 14 papers that have together received 292 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (4 papers), Chronic Myeloid Leukemia Treatments (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Eosinophilic Disorders and Syndromes (3 papers), Cancer Mechanisms and Therapy (1 paper), Acute Lymphoblastic Leukemia research (1 paper) and Neurological disorders and treatments (1 paper). The work is most often cited by research in Hematology (165 citations), Genetics (146 citations), Rheumatology (47 citations), Pathology and Forensic Medicine (40 citations) and Molecular Biology (99 citations). Ernst Schlögl has collaborated with scholars based in Austria, Germany and Italy. Frequent co-authors include Heinz Gisslinger, E. Pittermann, R. Heinz, Robert Pytlík, Michael Pfeilstöcker, Guenther Gastl, Michael Steurer, Heinz Tüchler, Maria‐Theresa Krauth and Thomas Nösslinger. Their work appears in journals such as Haematologica, American Journal of Hematology, Progress in brain research, Cancer and Leukemia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.